Development of functional Haemophilus Influenzae type b antibodies after vaccination of autologous stem cell transplant recipients

Haematologica

Volumn 90, Issue 11, 2005, Pages 1582-1584

  Van Der Velden, Ankie M T ^a,b,c   Claessen, Anke M E ^a   Van Velzen Blad, Heleen ^a   Biesma, Douwe H ^a   Rijkers, Ger T ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autologous stem cell transplantation; Haemophilus influenzae type b; Phagocytosis; Vaccination

Indexed keywords

CARMUSTINE; CYTARABINE; ETOPOSIDE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MELPHALAN;

ADULT; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PHAGOCYTOSIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; VACCINATION;

ADULT; ANTIBODIES, BACTERIAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; POLYSACCHARIDES, BACTERIAL; STEM CELL TRANSPLANTATION;

EID: 27844435623     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Lossos IS, Breuer R, Or R, Strauss N, Elishoov H, Naparstek E, et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 1995;60:672-8.
2. Frere P, Hermanne JP, Debouge MH, de Mol P, Fillet G, Beguin Y. Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplant 2004;33:745-9.
3. Ljungman P, Engelhard D, de la Camara R, Einsele H, Locasciulli A, Martino R, et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005;35:737-46.
4. Sullivan KM, Dykewicz CA, Longworth DL, Boeckh M, Baden LR, Rubin R, et al. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology Am Soc Hematol Educ Program 2001;392-421.
5. Martinez JE, Romero-Steiner S, Pilishvili T, Barnard S, Schinsky J, Goldblatt D, et al. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin Diagn Lab Immunol 1999;6:581-6.
6. Parkkali T, Kayhty H, Anttila M, Ruutu T, Wuorimaa T, Soininen A, et al. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines. Bone Marrow Transplant 1999;24:671-8.
7. Goldblatt D, Vaz AR, Miller E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis 1998;177:1112-5.
8. Breukels MA, Jol-van der Zijde E, van Tol MJ, Rijkers GT. Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed. Clin Infect Dis 2002;34:191-7.
9. Pullen GR, Fitzgerald MG, Hosking CS. Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods 1986;86:83-7.
10. Sanders LA, Feldman RG, Voorhorst-Ogink MM, de Haas M, Rijkers GT, Capel JA, et al. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun 1995;63:73-81.